Shares of PureTech Health plc (LON:PRTC - Get Free Report) were down 15.2% during mid-day trading on Tuesday . The company traded as low as GBX 117.20 ($1.53) and last traded at GBX 117.20 ($1.53). Approximately 42,764,352 shares changed hands during mid-day trading, an increase of 2,645% from the average daily volume of 1,557,904 shares. The stock had previously closed at GBX 138.20 ($1.81).
Wall Street Analyst Weigh In
Separately, Jefferies Financial Group restated a "buy" rating and set a GBX 455 ($5.95) target price on shares of PureTech Health in a research report on Monday, December 16th.
Check Out Our Latest Stock Report on PureTech Health
PureTech Health Stock Up 14.6 %
The company has a market capitalization of £354.45 million, a PE ratio of -4.84 and a beta of 1.02. The company's 50 day moving average is GBX 135.24 and its two-hundred day moving average is GBX 148.09. The company has a quick ratio of 2.51, a current ratio of 3.68 and a debt-to-equity ratio of 45.82.
About PureTech Health
(
Get Free Report)
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Featured Stories
Before you consider PureTech Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.
While PureTech Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
